This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Aelis Farma, Universitë De Bordeaux. Active years: 2026.
Company Filing History:
1 out of 3 
1 out of 226 
Years Active: 2026
Title: Aline Marighetto: Innovator in Cognitive Disorder Treatments
Introduction
Aline Marighetto is a notable inventor based in Bordeaux, France. She has made significant contributions to the field of cognitive disorders through her research and innovative approaches. Although she currently holds no granted patents, her work is focused on developing treatments that address cognitive impairments.
Latest Patent Applications
Aline Marighetto's latest patent application is for the compound 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one, which is intended for use in the treatment of cognitive disorders. This invention relates to a specific pregnenolone derivative that has shown potent effects in correcting cognitive impairments observed in such disorders. The compound of the invention is particularly noteworthy for its in vivo efficacy.
Conclusion
Aline Marighetto's work represents a promising avenue for the treatment of cognitive disorders, highlighting her commitment to innovation in this critical area of health. Her research continues to pave the way for future advancements in cognitive therapies.